ACONW

Aclarion, Inc. operates as a healthcare technology company focused on improving treatment outcomes for patients suffering from chronic lower back pain. Headquartered in Broomfield, Colorado, the company develops and commercializes advanced diagnostic tools utilizing magnetic resonance spectroscopy technology. Its flagship product, NOCISCAN, is a SaaS platform that analyzes MRI data to identify the specific source of chronic low back pain by measuring chemical biomarkers in the intervertebral discs. The technology aims to assist physicians in determining which patients are most likely to benefit from surgical intervention versus conservative treatment, addressing a significant clinical challenge given that approximately 85% of chronic lower back pain cases lack a definitive diagnosis. Aclarion targets the substantial market of chronic lower back pain sufferers, estimated at over 35 million people in the United States alone. The company pursues a business model centered on per-scan reimbursement and has been working to establish clinical evidence supporting NOCISCAN's efficacy and secure insurance coverage. Recent developments include ongoing efforts to expand clinical validation studies and pursue FDA regulatory pathways. As a pre-revenue or early-revenue stage medical technology company, Aclarion focuses its resources on product development, clinical studies, and market access initiatives rather than large-scale commercial operations.